Triphasic Randomized Clinical Trial: Comparative frequency of intermenstrual bleeding

William Droegemueller, Laura Rao Katta, Teresa G. Bright, Watson A. Bowes

Research output: Contribution to journalArticle

Abstract

Oral contraceptives have the highest theoretic efficacy of all reversible forms of contraception, yet in practice they have an actual failure rate equivalent to that of some barrier methods. The efficacy of oral contraceptives depends primarily on patient compliance. So-called "nuisance" side effects, such as intermenstrual bleeding (breakthrough bleeding or spotting), play a major role in their discontinuation. The Triphasic Randomized Clinical Trial compared the incidence of these side effects in three groups of subjects taking NET (A) (Ortho-Novum 7/7/7), LNG (Tri-Levlen), or NET (B) (Tri-Norinyl). Subjects taking NET (A) had the highest incidence of intermenstrual bleeding (63%) followed by NET (B) (44%) and LNG (33%). Only the difference between NET (A) and LNG attained statistical significance (p <0.030). Control subjects had no breakthrough bleeding and a 4% incidence of spotting. Further research is warranted to establish the cause of the disparity in the incidence of intermenstrual bleeding among patient groups assigned to the three oral triphasic contraceptives.

Original languageEnglish (US)
Pages (from-to)1407-1411
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume161
Issue number5
DOIs
StatePublished - 1989

Fingerprint

Metrorrhagia
Randomized Controlled Trials
Oral Contraceptives
Incidence
Patient Compliance
Contraception
Research

Keywords

  • adverse effects
  • breakthrough bleeding
  • comparative trials
  • intermenstrual bleeding
  • Oral contraceptives

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Triphasic Randomized Clinical Trial : Comparative frequency of intermenstrual bleeding. / Droegemueller, William; Katta, Laura Rao; Bright, Teresa G.; Bowes, Watson A.

In: American Journal of Obstetrics and Gynecology, Vol. 161, No. 5, 1989, p. 1407-1411.

Research output: Contribution to journalArticle

Droegemueller, William ; Katta, Laura Rao ; Bright, Teresa G. ; Bowes, Watson A. / Triphasic Randomized Clinical Trial : Comparative frequency of intermenstrual bleeding. In: American Journal of Obstetrics and Gynecology. 1989 ; Vol. 161, No. 5. pp. 1407-1411.
@article{e19ddff3a325499fb4ef3d07c60e71e9,
title = "Triphasic Randomized Clinical Trial: Comparative frequency of intermenstrual bleeding",
abstract = "Oral contraceptives have the highest theoretic efficacy of all reversible forms of contraception, yet in practice they have an actual failure rate equivalent to that of some barrier methods. The efficacy of oral contraceptives depends primarily on patient compliance. So-called {"}nuisance{"} side effects, such as intermenstrual bleeding (breakthrough bleeding or spotting), play a major role in their discontinuation. The Triphasic Randomized Clinical Trial compared the incidence of these side effects in three groups of subjects taking NET (A) (Ortho-Novum 7/7/7), LNG (Tri-Levlen), or NET (B) (Tri-Norinyl). Subjects taking NET (A) had the highest incidence of intermenstrual bleeding (63{\%}) followed by NET (B) (44{\%}) and LNG (33{\%}). Only the difference between NET (A) and LNG attained statistical significance (p <0.030). Control subjects had no breakthrough bleeding and a 4{\%} incidence of spotting. Further research is warranted to establish the cause of the disparity in the incidence of intermenstrual bleeding among patient groups assigned to the three oral triphasic contraceptives.",
keywords = "adverse effects, breakthrough bleeding, comparative trials, intermenstrual bleeding, Oral contraceptives",
author = "William Droegemueller and Katta, {Laura Rao} and Bright, {Teresa G.} and Bowes, {Watson A.}",
year = "1989",
doi = "10.1016/0002-9378(89)90705-9",
language = "English (US)",
volume = "161",
pages = "1407--1411",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Triphasic Randomized Clinical Trial

T2 - Comparative frequency of intermenstrual bleeding

AU - Droegemueller, William

AU - Katta, Laura Rao

AU - Bright, Teresa G.

AU - Bowes, Watson A.

PY - 1989

Y1 - 1989

N2 - Oral contraceptives have the highest theoretic efficacy of all reversible forms of contraception, yet in practice they have an actual failure rate equivalent to that of some barrier methods. The efficacy of oral contraceptives depends primarily on patient compliance. So-called "nuisance" side effects, such as intermenstrual bleeding (breakthrough bleeding or spotting), play a major role in their discontinuation. The Triphasic Randomized Clinical Trial compared the incidence of these side effects in three groups of subjects taking NET (A) (Ortho-Novum 7/7/7), LNG (Tri-Levlen), or NET (B) (Tri-Norinyl). Subjects taking NET (A) had the highest incidence of intermenstrual bleeding (63%) followed by NET (B) (44%) and LNG (33%). Only the difference between NET (A) and LNG attained statistical significance (p <0.030). Control subjects had no breakthrough bleeding and a 4% incidence of spotting. Further research is warranted to establish the cause of the disparity in the incidence of intermenstrual bleeding among patient groups assigned to the three oral triphasic contraceptives.

AB - Oral contraceptives have the highest theoretic efficacy of all reversible forms of contraception, yet in practice they have an actual failure rate equivalent to that of some barrier methods. The efficacy of oral contraceptives depends primarily on patient compliance. So-called "nuisance" side effects, such as intermenstrual bleeding (breakthrough bleeding or spotting), play a major role in their discontinuation. The Triphasic Randomized Clinical Trial compared the incidence of these side effects in three groups of subjects taking NET (A) (Ortho-Novum 7/7/7), LNG (Tri-Levlen), or NET (B) (Tri-Norinyl). Subjects taking NET (A) had the highest incidence of intermenstrual bleeding (63%) followed by NET (B) (44%) and LNG (33%). Only the difference between NET (A) and LNG attained statistical significance (p <0.030). Control subjects had no breakthrough bleeding and a 4% incidence of spotting. Further research is warranted to establish the cause of the disparity in the incidence of intermenstrual bleeding among patient groups assigned to the three oral triphasic contraceptives.

KW - adverse effects

KW - breakthrough bleeding

KW - comparative trials

KW - intermenstrual bleeding

KW - Oral contraceptives

UR - http://www.scopus.com/inward/record.url?scp=0024404875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024404875&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(89)90705-9

DO - 10.1016/0002-9378(89)90705-9

M3 - Article

C2 - 2686457

AN - SCOPUS:0024404875

VL - 161

SP - 1407

EP - 1411

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -